Skip to content
XPR
content.
Press releases
Video
Podcasts
Op-eds
Lists
Guest posts
Author:
IRLAB Therapeutics
New Number of Shares and Votes in IRLAB Therapeutics AB
July 31, 2026
Report from the Annual General Meeting 2026 of IRLAB Therapeutics AB
June 30, 2026
IRLAB Presents Integrated Analysis of Mesdopetam Data at International Conference – Confirms Robust Efficacy Results in the Phase II Studies
June 16, 2026
Report from the Extraordinary General Meeting of IRLAB Therapeutics AB
June 5, 2026
IRLAB Participates at Aktiedagarna in Stockholm on June 9
June 3, 2026